PT-141

PT-141 (bremelanotide) is a peptide that acts on melanocortin receptors in the brain, which are involved in sexual desire and arousal. Unlike many options, it works on the nervous system rather than on blood flow.

Who it may help

• Adults with low sexual desire that causes distress
• People who want to explore an option beyond blood-flow medications

What your consultation covers

• A private conversation about your goals, health history and medications
• Blood pressure and heart health screening
• If prescribed: how and when to use it, what to expect and follow-up

Good to know

• Prescription only. Bremelanotide is FDA-approved, as Vyleesi, for premenopausal women with acquired hypoactive sexual desire disorder; other uses are off-label.
• Common side effects include nausea, flushing and headache. It can briefly raise blood pressure, so it isn't suitable with uncontrolled high blood pressure or heart disease.

This information is educational and isn't medical advice. Results vary.